Skip to content
synovial sarcoma foundation
  • About
    • Mission
    • Initiatives
    • Affiliations
    • Leadership
    • Board of Directors
    • Medical Advisory Board
    • Careers
  • Resources
    • Synovial Sarcoma FAQ
    • Treatments
    • Clinical Trials & Therapies
    • Synovial Sarcoma Patient Survey
    • Synovial Sarcoma Tumor Board
    • Patient Stories
    • Patient Resources
    • Eddie’s Story
    • Video Resources
    • SSF Ambassador Program
  • Research Programs
    • Clinical Research
    • Tumor Glow
    • Synovial Sarcoma Registry
  • Latest News
Donate

Send us a note

Please fill out the form below and we will gladly respond as soon as possible.



    Patient Story, Synovial Sarcoma Registry

    In Conversation with Kaela: How Research Gave a Mom of Two a Second Chance at Life

    August 11, 2026 ayushis Comments Off on In Conversation with Kaela: How Research Gave a Mom of Two a Second Chance at Life
    A collage showing a woman in various moments: in a headscarf, in military attire, hugging her children, on her wedding day, and smiling with her family. Text reads, “Kaela’s Story.”.

    Kaela Graham-Bowman’s story reached national audiences this year when she was featured on 60 Minutes Australia. An Afghanistan veteran and nurse, Kaela was diagnosed with synovial sarcoma in 2020 at age 28, while working as an oncology nurse herself. What followed was a six-year fight through surgery, chemotherapy, a devastating relapse, and eventually a groundbreaking treatment that gave her and her two kids a future she wasn’t sure she’d have.

    Kaela became the first Australian to access Tecelra (afamitresgene autoleucel), an engineered T-cell therapy built specifically to target synovial sarcoma cells. After her cancer returned and spread to both lungs in 2022, a moment she has described as feeling like her life was over, she exhausted every treatment available to her at home before traveling to the US for the roughly $2 million therapy, supported by Australia’s Medical Treatment Overseas Program. The results have been striking: scans have shown one tumor shrink from 7cm to 1cm and another from 4cm to 1cm, with a third holding stable and no disease detected elsewhere.

    Julie Kramer, our Community Engagement and Partnerships Manager at SSF, sat down with Kaela to go beyond the headlines and talk about what that journey actually looked like, and what she wants other patients to take from it.

    A woman with long hair wearing a colorful headscarf is shown alongside photos of her with children, in a wedding dress, in military uniform, and smiling with family.

    Pictures: news.com.au

    A Diagnosis No One Expected

    Kaela’s path to diagnosis started with pain in her thigh that she initially put down to an old army injury. A GP sent her for an ultrasound, and one doctor’s instinct changed everything.

    “One of the doctors had seen a sarcoma before. And she was like, we need to rule out sarcoma. And I was just like, what’s that?”

    Even as a working oncology nurse, Kaela had never encountered synovial sarcoma before. By the time she was diagnosed, the tumor was already wrapping around her femoral artery, forcing surgeons to perform an emergency full resection mid-biopsy. Chemotherapy started within a month, and she credits staying in her nursing job through treatment with keeping her going, telling 60 Minutes that losing her sense of purpose would have meant losing the fight.

    Why Research Made the Difference

    Kaela is candid about what saved her life: research. Without it, she believes she wouldn’t be here.

    “Without TECELRA, without the research, I truly, in my heart, think I would be gone now. TECELRA is the first really promising thing for synovial sarcoma that we’ve had in so long. And there’s not enough research because there’s not enough funding.”

    That’s the heart of what makes Kaela’s story so important to share. Synovial sarcoma is rare, aggressive, and chronically underfunded compared to more common cancers, which means every trial, every approved therapy, and every treatment breakthrough exists because patients before her chose to participate in research. Kaela didn’t just benefit from that system; she’s now part of it. She’s donated her own tumor tissue to the SSF Synovial Sarcoma Registry & Biorepository, turning the disease that nearly killed her into a resource that could help researchers find answers for the next patient.

    “As ugly as it is, like this whole process, the whole disease, it’s so exciting being part of something like that. If I’m going to die, the least I can do is provide what’s trying to kill me to research so that someone else doesn’t have to go through that.”

    Advocate for Yourself

    Kaela’s clinical background gave her the confidence to push back, ask for second opinions, and refuse to be written off as a statistic, something she believes every patient deserves the tools to do, regardless of medical background.

    “Advocate for yourself. If you don’t know how to advocate or what to ask, look it up… know that you can have a second opinion. And if your gut is telling you that something’s not right, believe it and question it. Advocacy for yourself is the most powerful thing you can have.”

    Watch Kaela’s Story

    Kaela’s full story aired on 60 Minutes Australia. Watch it here: Pioneering treatment for the rarest of cancers gives hope for terminal patients

    Join Kaela in Advancing Research

    Kaela has donated her own tumor tissue to the Synovial Sarcoma Registry & Biorepository, a first-of-its-kind initiative funded by SSF and housed at Children’s Hospital of Philadelphia in partnership with Penn Medicine. It’s the reason treatments like the one that saved her life exist, and every new participant helps bring the next one closer.

    You can be part of what comes next. Join Kaela and enroll in the SSF Registry & Biorepository.

    Enroll in the Registry & Biorepository →

    Questions? Email SynovialSarcomaRegistry@chop.edu or call +1 267-827-8145.

    Readers can find the full news.com.au feature on Kaela’s journey here: ‘Game-changing’ treatment giving hope for 35yo mum after terminal cancer diagnosis.

    • and rare cancer awareness sarcoma
    • donate tumor tissue sarcoma research
    • engineered T-cell therapy cancer
    • first Australian to receive Tecelra
    • how effective is Tecelra for synovial sarcoma
    • how to get synovial sarcoma treatment overseas
    • rare cancer treatment breakthrough
    • sarcoma patient donates tumor to research
    • SSF Registry and Biorepository
    • Synovial Sarcoma
    • synovial sarcoma clinical trial success story
    • Synovial Sarcoma Foundation
    • synovial sarcoma relapse and metastasis to lungs
    • synovial sarcoma survivor story
    • synovial sarcoma symptoms in young adults
    • synovial sarcoma T-cell therapy
    • synovial sarcoma treatment
    • synovial sarcoma treatment cost
    • Tecelra afamitresgene autoleucel
    • what is synovial sarcoma
    ayushis

    Post navigation

    Previous
    Next

    Search

    Categories

    • Black Flag Racing (2)
    • Case Study (5)
    • Children (1)
    • CHOP (3)
    • Clinical Trial (4)
    • Development (12)
    • Dr. Theodore Laetsch (3)
    • Education (27)
    • Europe Expansion (1)
    • Healthcare (13)
    • Latest News (22)
    • Patient Story (1)
    • Programs (1)
    • Rare Cancer (7)
    • Rare Cancer Funding (2)
    • Research (21)
    • SSF Ambassador Program (1)
    • Synovial Sarcoma Conference (2)
    • Synovial Sarcoma Registry (7)
    • Teresa Belluco (1)
    • Tumor Board (2)

    Recent posts

    • A doctor in a white coat with a stethoscope around their neck holds a tablet device, standing in a medical setting with a patient lying on a bed in the background.
      Synovial Sarcoma of the Tibial Nerve: A Case of Diagnostic Ambiguity and Limb Salvage
    • A scientist wearing blue gloves adjusts a microscope slide.
      Can We Reactivate T Cells After TCR-T Therapy Stops Working?
    • Hands wearing blue nitrile gloves draw liquid from a small glass vial into a syringe, with a rack of test tubes in the background.
      Why Every Tumor Sample Matters: What a New Sarcoma Biobank Study Means for Synovial Sarcoma

    Tags

    #AYACancer #CancerResearch #CaseReport #CellTherapy #ClinicalTrials #Immunotherapy #KnowYourOptions #MAGEA4 #MolecularDiagnostics #NYESO1 #PatientAdvocacy #RareCancer #RareDisease #Sarcoma #SarcomaAwareness #SoftTissueSarcoma #SS18SSX #SynovialSarcoma #SynovialSarcomaFoundation #TumorBoard Afami-cel Afamitresgene autoleucel Cancer Research CHOP immunotherapy MAGE-A4 synovial sarcoma NY-ESO-1 synovial sarcoma precision medicine Rare Cancer rare cancer research rare soft tissue sarcoma research sarcoma research sarcoma treatment soft tissue sarcoma Synovial Sarcoma synovial sarcoma biomarker testing synovial sarcoma diagnosis Synovial Sarcoma Foundation synovial sarcoma immunotherapy synovial sarcoma treatment T-Cell Therapy targeted therapy TCR Therapy TECELRA

    Related posts

    A scientist wearing blue gloves adjusts a microscope slide.
    Clinical Trial, Development

    Can We Reactivate T Cells After TCR-T Therapy Stops Working?

    November 3, 2026 ayushis Comments Off on Can We Reactivate T Cells After TCR-T Therapy Stops Working?

    A new pilot trial at Northwestern University is asking one of the most important questions in synovial sarcoma treatment: when TCR-T therapy stops working, are the T cells truly gone, or can they be brought back to life? Background: The Promise and the Limit of TCR-T Therapy TCR-T cell therapy represents a major advance for […]

    Hands wearing blue nitrile gloves draw liquid from a small glass vial into a syringe, with a rack of test tubes in the background.
    Latest News, Synovial Sarcoma Registry

    Why Every Tumor Sample Matters: What a New Sarcoma Biobank Study Means for Synovial Sarcoma

    October 28, 2026 ayushis Comments Off on Why Every Tumor Sample Matters: What a New Sarcoma Biobank Study Means for Synovial Sarcoma

    A new study in Advanced Science (October 12, 2026) shows what becomes possible when patients donate tumor tissue and researchers pair it with detailed clinical and genetic data. The same idea drives the Synovial Sarcoma Registry and Biorepository, and every patient who joins makes the next study possible. What the study found Over ten years, […]

    Close-up of blue gloved hands adjusting a microscope with two visible objective lenses, focusing on a glass slide in a laboratory setting.
    Education, Research

    The Cells Around the Tumor May Hold the Key to Improving Immunotherapy in Synovial Sarcoma

    September 14, 2026 ayushis Comments Off on The Cells Around the Tumor May Hold the Key to Improving Immunotherapy in Synovial Sarcoma

    A new study published in PLOS One by Ji-Yong Sung, Jin-Hong Kim, and Yi-Jun Kim from Seoul National University and Ewha Womans University, South Korea, examines a type of cell found in the tissue surrounding tumors, called cancer-associated fibroblasts (CAFs), and asks whether they can predict how a sarcoma patient will respond to immunotherapy. What […]

    The Synovial Sarcoma Foundation is a registered 501(c)(3) nonprofit organization. Tax ID number is 33-4027591. Contributions to the Synovial Sarcoma Foundation are tax-deductible to the extent permitted by law.

    • Terms & conditions
    • Privacy policy
    synovial sarcoma foundation
    • community@synovialsarcoma.org
    1025 Thomas Jefferson St. NW, Suite W-3200, Washington DC 20007
    Facebook-f X-twitter Linkedin

    Navigation

    • About
    • Research Programs
    • Patient Stories
    • Resources

    Stay in touch